Загрузка...
Therapeutic Drug Monitoring in 21‐Day Oral Etoposide Treatment for Lung Cancer
We aimed to determine whether or not therapeutic drug monitoring is applicable to 21‐day oral etoposide treatment for lung cancer. As the starting dose, a 25‐mg capsule of etoposide was taken orally three times daily (75 mg/body). To achieve the target concentration range of 1.0 to 1.5 μg/ml, the do...
Сохранить в:
| Опубликовано в: : | Jpn J Cancer Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Blackwell Publishing Ltd
1996
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5921180/ https://ncbi.nlm.nih.gov/pubmed/8797893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb02111.x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|